MedPath

Ziabitos capsule effect on blood glucose control

Not Applicable
Conditions
Diabet.
Diabetes Mellitus
E10-E14
Registration Number
IRCT201108107286N1
Lead Sponsor
Shahed University Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

1-Age: 30 – 70 years
2-Uncontrolled Type 2 Diabetes: (HbA1c >7%)
3-Treated with oral diabetes medications (one or more Pharmaceutical group)
4-Over at least a month, since the addition of anti-diabetic drug dosage or prescribe a new anti-diabetic drug
?Exclusion criteria:
1-GFR (Glomerular Filtration Rate) < 60 ml/mi
2-Serum Alb < 4 gr/dl
3 - High SGOT and SGPT: more than three times the normal

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
2h postparandial blood suger. Timepoint: Before and four weeks after Intervention. Method of measurement: Mg per deciliter and a lab kit.;Serum Fructosamine. Timepoint: Before and four weeks after Intervention. Method of measurement: Micromol per liter and a lab kit.;Fasting Blood Sugar. Timepoint: Before and four weeks after Intervention. Method of measurement: Mg per deciliter and a lab kit.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath